Details for New Drug Application (NDA): 214492
✉ Email this page to a colleague
NDA 214492 describes ZONISAMIDE, which is a drug marketed by Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Bionpharma, Epic Pharma Llc, Glenmark Pharms Inc, Granules, Heritage Pharma Avet, Invagen Pharms, Norvium Bioscience, Rising, Roxane, Sun Pharm Inds (in), Sun Pharm Industries, Unichem, Upsher Smith Labs, and Zydus Lifesciences, and is included in eighteen NDAs. It is available from nineteen suppliers. Additional details are available on the ZONISAMIDE profile page.
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 214492
| Tradename: | ZONISAMIDE |
| Applicant: | Unichem |
| Ingredient: | zonisamide |
| Patents: | 0 |
Pharmacology for NDA: 214492
| Mechanism of Action | Carbonic Anhydrase Inhibitors P-Glycoprotein Inhibitors |
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 214492
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZONISAMIDE | zonisamide | CAPSULE;ORAL | 214492 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-428 | 29300-428-01 | 100 CAPSULE in 1 BOTTLE (29300-428-01) |
| ZONISAMIDE | zonisamide | CAPSULE;ORAL | 214492 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-428 | 29300-428-05 | 500 CAPSULE in 1 BOTTLE (29300-428-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
| Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
